BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22911524)

  • 1. Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.
    Pećina-Slaus N; Zeljko M; Pećina HI; Nikuseva Martić T; Bacić N; Tomas D; Hrasćan R
    Croat Med J; 2012 Aug; 53(4):321-7. PubMed ID: 22911524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of the Loss of Heterozygosity of the
    DE Carvalho RM; DE Castro Sant' Anna C; Pinto GR; Paschoal EHA; Tuji FM; DO Nascimento Borges B; Soares PC; Júnior AGF; Rey JA; Chaves LCL; Burbano RR
    Anticancer Res; 2018 Apr; 38(4):2149-2154. PubMed ID: 29599333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
    Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
    Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
    Lasota J; Wasag B; Dansonka-Mieszkowska A; Karcz D; Millward CL; Ryś J; Stachura J; Sobin LH; Miettinen M
    Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
    Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
    Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
    Hung G; Faudoa R; Baser ME; Xue Z; Kluwe L; Slattery W; Brackman D; Lim D
    Cancer Genet Cytogenet; 2000 Apr; 118(2):167-8. PubMed ID: 10748301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in malignant rat schwannomas chemically induced in hybrids of inbred rat strains with differential tumor susceptibility.
    Koelsch BU; Kindler-Röhrborn A; Held S; Zabel S; Rajewsky MF
    Carcinogenesis; 2002 Jun; 23(6):1033-7. PubMed ID: 12082026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?
    Leverkus M; Kluwe L; Röll EM; Becker G; Bröcker EB; Mautner VF; Hamm H
    Br J Dermatol; 2003 Apr; 148(4):804-9. PubMed ID: 12752143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
    Jacoby LB; Jones D; Davis K; Kronn D; Short MP; Gusella J; MacCollin M
    Am J Hum Genet; 1997 Dec; 61(6):1293-302. PubMed ID: 9399891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
    Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
    Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
    Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
    Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of embedded nerve tissue in six NF2-associated schwannomas and 17 nonassociated NF2 schwannomas.
    Hamada Y; Iwaki T; Fukui M; Tateishi J
    Surg Neurol; 1997 Oct; 48(4):395-400. PubMed ID: 9315139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas.
    Sainz J; Figueroa K; Baser ME; Pulst SM
    Hum Genet; 1996 Jan; 97(1):121-3. PubMed ID: 8557252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
    Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
    J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization.
    Begnami MD; Palau M; Rushing EJ; Santi M; Quezado M
    Hum Pathol; 2007 Sep; 38(9):1345-50. PubMed ID: 17509660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
    Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
    Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.